Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Northern CapSek Ventures PREF | CAPSPREF | Mar 27, 2024 | 0.50 | 0.00 |
Northgold | NG | Mar 27, 2024 | 3.60 | 0.00 |
Norva24 | NORVA | Mar 27, 2024 | 25.25 | -0.59 |
Nosa Plugs | NOSA | Mar 27, 2024 | 0.50 | -5.17 |
Nosium | NOSIUMB | Mar 27, 2024 | 0.02 | -31.82 |
Note | NOTE | Mar 27, 2024 | 145.80 | +2.03 |
Novotek B | NTEKB | Mar 27, 2024 | 64.70 | -1.07 |
Novus Group | NOVU | Mar 27, 2024 | 3.34 | 0.00 |
Nowonomics | NOWO | Mar 27, 2024 | 3.55 | +5.34 |
NP3 Fastigheter | NP3 | Mar 27, 2024 | 224.20 | +3.03 |
NP3 Fastigheter Pref | NP3PREF | Mar 27, 2024 | 27.95 | +0.54 |
Nyfosa | NYF | Mar 27, 2024 | 104.10 | +3.17 |
Nykode Therapeutics | NYKDO | Mar 27, 2024 | 14.10 | 0.00 |
Obducat B | OBDUB | Mar 27, 2024 | 1.71 | -0.58 |
Observit | OBSE | Mar 27, 2024 | 0.17 | 0.00 |
ODI Pharma | ODI | Mar 27, 2024 | 5.25 | +1.94 |
Odinwell | ODIN | Mar 27, 2024 | 0.78 | -0.64 |
OEM International B | OEMB | Mar 27, 2024 | 104.20 | +1.17 |
Ogunsen B | OGUNB | Mar 27, 2024 | 42.50 | +1.19 |
OmniCar | OMNI | Mar 27, 2024 | 0.04 | -7.32 |
OMX GES OMXS30 Ethical Price Index | OMXS30ETHIC | Mar 27, 2024 | 300.55 | -0.40 |
OMX NORDIC 40 | OMXN40 | Mar 27, 2024 | 2 775.21 | -0.70 |
OMX Oslo 20 GI | OMXO20GI | Mar 27, 2024 | 1 206.89 | +0.27 |
OMX Oslo 20 PI | OMXO20PI | Mar 27, 2024 | 698.28 | +0.27 |
OMX Stockholm 30 | OMXS30 | Mar 27, 2024 | 2 537.37 | -0.42 |
OMX Stockholm 30 GI | OMXS30GI | Mar 27, 2024 | 490.14 | -0.08 |
OMX Stockholm 60 Cap PI | OMXS60CAP | Mar 27, 2024 | 312.58 | -0.31 |
OMX Stockholm 60 PI | OMXS60PI | Mar 27, 2024 | 293.76 | -0.35 |
OMX Stockholm Automobiles & Parts PI | SX4010PI | Mar 27, 2024 | 1 728.14 | +1.62 |
OMX Stockholm Banks PI | SX3010PI | Mar 27, 2024 | 1 940.61 | -4.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.